4//SEC Filing
Swabb Edward 4
Accession 0001181431-09-034350
CIK 0001459450other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:46 PM ET
Size
5.2 KB
Accession
0001181431-09-034350
Insider Transaction Report
Form 4
Swabb Edward
SVP, Drug Development, CMO
Transactions
- Award
Common Stock
2009-07-01+15,000→ 15,000 total
Footnotes (1)
- [F1]Consists of a restricted stock unit award made pursuant to the Issuer's 2009 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest over a three-year period as to 1/3 of the units on each of June 15, 2010, June 15, 2011 and June 15, 2012.
Documents
Issuer
Myriad Pharmaceuticals, Inc.
CIK 0001459450
Entity typeother
Related Parties
1- filerCIK 0001465950
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:46 PM ET
- Size
- 5.2 KB